Showing results (941-950 of 1,209) with videos related to
Sort By:
Pageof 121
AIDS (London, England)|November 11, 2016
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general populationAysel Gueler, André Moser, Alexandra Calmy, et al.BJU International|August 7, 2023
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre studyMarc A Furrer, Niranjan Sathianathen, Brigitta Gahl, et al.Urology|June 3, 2024
Retrograde Ureteral Stents Versus Percutaneous Nephrostomy in the Management of Malignant Ureteral Obstruction: A Systematic Review and Meta-AnalysisMohammad Usman Ahmad, Saad Siddiqui, Faisal Amir Ashraf, et al.Blood|June 10, 2004
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set pointAlexandra Trkola, Herbert Kuster, Christine Leemann, et al.JMIR Research Protocols|December 10, 2021
Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysisZoë Tremblay, David Mumbere, Danielle Laurin, et al.HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort StudyTracy R Glass, Manuel Battegay, Matthias Cavassini, et al.Archives of Internal Medicine|October 15, 2003
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort StudyGilbert R Kaufmann, Luc Perrin, Guiseppe Pantaleo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D studyMathias Bruyand, Lene Ryom, Leah Shepherd, et al.HIV Medicine|February 26, 2015
Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialA C Achhra, A Mocroft, M J Ross, et al.Pageof 121